TrianglePUBLICATIONS · 8464233
Mitoxantrone, etoposide and intermediate-dose Ara-C (MEC): an effective regimen for poor risk acute myeloid leukemia.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Leukemia
- Publication date
- 1993 Apr
- First author
- Spadea A
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Spadea A
- type
- Author
- name
- Petti MC
- type
- Author
- name
- Fazi P
- type
- Author
- name
- Vegna ML
- type
- Author
- name
- Arcese W
- type
- Author
- name
- Avvisati G
- type
- Author
- name
- Aloe Spiriti MA
- type
- Author
- name
- Latagliata R
- type
- Author
- name
- Meloni G
- type
- Author
- name
- Testi AM
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Spadea A
- type
- Author
- name
- Petti MC
- type
- Author
- name
- Fazi P
- type
- Author
- name
- Vegna ML
- type
- Author
- name
- Arcese W
- type
- Author
- name
- Avvisati G
- type
- Author
- name
- Aloe Spiriti MA
- type
- Author
- name
- Latagliata R
- type
- Author
- name
- Meloni G
- type
- Author
- name
- Testi AM
- type
- Author
- bibliography ids
- nci-bib-74a60687d1a2b0cd779ac865
- book metadata
- content sha256
- 87328602a62f0cc5a9b78ef45bef6c7d40143ea087dce91196bde15add91ff26
- document type
- citation
- dois
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:8464233
- immutable id
- pubmed:8464233@87328602a62f0cc5a9b78ef45bef6c7d40143ea087dce91196bde15add91ff26
- journal
- abbreviation
- Leukemia
- issn electronic
- Source null
- issn print
- 0887-6924
- issue
- 4
- name
- Leukemia
- nlm unique id
- 8704895
- pages
- 549-52
- volume
- 7
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 8464233
- provenance
- batch id
- 6de860041cedd40f623b
- provider
- NCBI PubMed ESummary
- record sha256
- dfb35b3146af6259b0c6cf9e2c02457290bb214d75c2598898aa7df00dac0a5b
- response sha256
- f46103bbddb69bd5f2ea5fd2e8d9cab75a19eeb01ce2a0d1f98b4d456a872039
- retrieved at
- 2026-09-09T23:45:23.163950+00:00
- publication date
- display
- 1993 Apr
- precision
- month
- year
- 1993
- publication types
- Clinical Trial
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/8464233/
- title
- Mitoxantrone, etoposide and intermediate-dose Ara-C (MEC): an effective regimen for poor risk acute myeloid leukemia.
Preserved source evidence · Not medical advice